David Domzalski
2023
In 2023, David Domzalski earned a total compensation of $2.7M as President and Chief Executive Officer at VYNE Therapeutics, a 110% increase compared to previous year.
Compensation breakdown
| Bonus | $382,536 |
|---|---|
| Non-Equity Incentive Plan | $573,804 |
| Option Awards | $501,750 |
| Salary | $637,560 |
| Stock Awards | $607,500 |
| Other | $13,200 |
| Total | $2,716,350 |
Domzalski received $637.6K in salary, accounting for 23% of the total pay in 2023.
Domzalski also received $382.5K in bonus, $573.8K in non-equity incentive plan, $501.8K in option awards, $607.5K in stock awards and $13.2K in other compensation.
Rankings
In 2023, David Domzalski's compensation ranked 348th out of 2,983 executives tracked by ExecPay. In other words, Domzalski earned more than 88.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 348 out of 2,983 | 88th |
Division Manufacturing | 198 out of 1,637 | 88th |
Major group Chemicals And Allied Products | 135 out of 906 | 85th |
Industry group Drugs | 132 out of 869 | 85th |
Industry Pharmaceutical Preparations | 82 out of 627 | 87th |
Source: SEC filing on November 12, 2024.
Domzalski's colleagues
We found two more compensation records of executives who worked with David Domzalski at VYNE Therapeutics in 2023.
News
VYNE Therapeutics CEO David Domzalski's 2023 pay jumps 110% to $2.7M
November 12, 2024
VYNE Therapeutics CEO David Domzalski's 2022 pay falls 73% to $1.3M
November 13, 2023
VYNE Therapeutics CEO David Domzalski's 2021 pay jumps 69% to $4.9M
June 17, 2022
VYNE Therapeutics CEO David Domzalski receives $2.9M in 2020
June 7, 2021